Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sanofi (SNYNF)
OTHER OTC:SNYNF
SNYNF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$90.15 - $121.06
Previous CloseN/A
Volume2.00
Average Volume (3M)18.87K
Market Cap
$136.31B
Enterprise Value$128.59B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)22.6
Beta0.34
Next Earnings
Apr 24, 2025EPS Estimate
1.69Last Dividend Ex-Date
May 13, 2024Dividend Yield3.78%
Share Statistics
EPS (TTM)4.81
Shares Outstanding1,263,122,700
10 Day Avg. Volume305
30 Day Avg. Volume18,874
Standard Deviation0.07
R-Squared0.08
Alpha0.00286
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.87
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$120.32Price Target Upside10.95% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
---
Bulls Say, Bears Say
Bulls Say
Financial StrategyThe company's fiscal year 2025 guidance includes a significant share buyback program of 5 billion euros, indicating confidence in the company's financial health.
Product LaunchDupixent’s COPD launch is expected to become an important growth driver due to the large unmet medical need.
Bears Say
Market VolatilityThere could be stock volatility when SAN reports results on January 30.
---
Ownership Overview
―
Insiders
13.15% Mutual Funds
<0.01% Other Institutional Investors
72.58% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
SNYNF FAQ
What was Sanofi’s price range in the past 12 months?
Sanofi lowest stock price was $90.15 and its highest was $121.06 in the past 12 months.
What is Sanofi’s market cap?
Sanofi’s market cap is $136.31B.
When is Sanofi’s upcoming earnings report date?
Sanofi’s upcoming earnings report date is Apr 24, 2025 which is in 61 days.
How were Sanofi’s earnings last quarter?
Sanofi released its earnings results on Jan 30, 2025. The company reported $1.368 earnings per share for the quarter, missing the consensus estimate of $1.413 by -$0.045.
Is Sanofi overvalued?
According to Wall Street analysts Sanofi’s price is currently Undervalued.
Does Sanofi pay dividends?
Sanofi pays a Annually dividend of $3.931 which represents an annual dividend yield of 3.78%. See more information on Sanofi dividends here
What is Sanofi’s EPS estimate?
Sanofi’s EPS estimate is 1.69.
How many shares outstanding does Sanofi have?
Sanofi has 1,263,122,700 shares outstanding.
What happened to Sanofi’s price movement after its last earnings report?
Sanofi reported an EPS of $1.368 in its last earnings report, missing expectations of $1.413. Following the earnings report the stock price went up 3.093%.
Which hedge fund is a major shareholder of Sanofi?
Currently, no hedge funds are holding shares in SNYNF
---
Company Description
Sanofi
Sanofi engages in the research, production and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Human Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes & cardiovascular, established prescription products and generics, together with research, development and production activities. This segment also includes all associates whose activities are related to pharmaceuticals. The Consumer Healthcare segment comprises, for all geographical territories, the commercial operations for its Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development and production activities dedicated to vaccines. The company was founded in 1973 and is headquartered in Paris, France.
---
SNYNF Company Deck
---
SNYNF Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive sentiment overall, driven by strong sales growth, successful product launches, and significant R&D advancements. Despite some challenges like gross margin pressure and increased expenses, the company's strategic focus on innovation and market expansion supports a strong outlook.Read More>---
SNYNF Stock 12 Month Forecast
Average Price Target
$120.32
▲(10.95% Upside)
Technical Analysis
Best Analysts Covering SNYNF
1 Year
---